Dengvaxia permanently banned in PH
Dengvaxia’s certificates of product registration (CPRs) have been “permanently revoked,” the Food and Drug Administration (FDA) announced Tuesday, February 19. This is due to the continued failure of the anti-dengue vaccine manufacturer, Sanofi Pasteur Inc., to submit post-approval commitment documents. According to FDA Director General Nela Charade Puno, Sanofi Pasteur has “shown complete disregard of…